Healing of Fracture Clinical Trial
The investigators hypothesized that mesenchymal stem cells can be isolated from fracture site, iliac crest, and tibial crest, and can be expanded to be used in the management of nonunion fracture.
| Status | Recruiting |
| Enrollment | 10 |
| Est. completion date | January 2016 |
| Est. primary completion date | April 2015 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years to 55 Years |
| Eligibility |
Inclusion Criteria: - athropic nonunion fracture of the long bone Exclusion Criteria: - immunocompromise, - active infection, - pathological fracture, - ongoing hormonal therapy |
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| Indonesia | RSCM | Jakarta |
| Lead Sponsor | Collaborator |
|---|---|
| Indonesia University |
Indonesia,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | healing of fracture | radiological union | 1 year | No |
| Secondary | VAS | visual analogue scale | 1 year | No |